Impact Biomedical (IBO) Price to Book (2024 - 2026)

Impact Biomedical (IBO) has reported Price to Book for 3 consecutive years, with 3.54 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Book rose 429.81% year-over-year to 3.54; the trailing twelve-month figure through Jun 2026 stood at 3.54 (up 429.81% YoY), and the FY2025 full-year result was 1.01, up 24219.26% from the prior year.
• Price to Book eased to 3.54 in Q2 2026 per IBO's latest filing, from 4.4 in the prior quarter.
• Across five years, Price to Book topped out at 4.4 in Q1 2026 and bottomed at 1.07 in Q2 2025.
• Historically, Price to Book has averaged 1.46 across 3 years, with a median of 1.28 in 2025.
• The sharpest annual moves came in 2025 and 2026: Price to Book plunged 203.22% in 2025, then jumped 429.81% in 2026.
• Over 3 years, Price to Book stood at 2.3 in 2024, then tumbled by 56.0% to 1.01 in 2025, then jumped by 249.02% to 3.54 in 2026.
• According to Business Quant data, Price to Book over the past three periods registered 3.54, 4.4, and 1.01 for Q2 2026, Q1 2026, and Q4 2025 respectively.